Ransom Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Ransom Advisory’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$573K	Sell	10,626 -1,400	-12%	-$67.3K	0.23%	76
2025 Q3	$542K	Sell	12,026 -1,300	-10%	-$60.7K	0.24%	67
2025 Q2	$617K	Sell	13,326 -500	-4%	-$24.5K	0.29%	64
2025 Q1	$843K	Buy	13,826 +700	+5%	+$40.8K	0.42%	54
2024 Q4	$742K	Sell	13,126 -1,000	-7%	-$55.9K	0.34%	59
2024 Q3	$731K	Sell	14,126 -5,372	-28%	-$252K	0.34%	59
2024 Q2	$810K	Buy	19,498 +100	+0.5%	+$4.47K	0.41%	53
2024 Q1	$1.05M	Buy	+19,398	New	+$988K	0.56%	41

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ransom Advisory's BMY Position: Q4 2025 in Review

Ransom Advisory reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q4 2025, selling an estimated $67.3K and leaving 10,626 shares worth $573K. The position accounts for 0.23% of the portfolio, ranked #76.

Ransom Advisory first reported a position in BMY in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.05M in Q1 2024. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Ransom Advisory held 10,626 shares of Bristol-Myers Squibb worth $573K as of Q4 2025.
Ransom Advisory sold 1,400 Bristol-Myers Squibb shares in Q4 2025, an estimated $67.3K.
Bristol-Myers Squibb made up 0.23% of Ransom Advisory's portfolio in Q4 2025, its #76 holding.
Ransom Advisory first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 8 quarters since.
Ransom Advisory's Bristol-Myers Squibb position peaked at $1.05M in Q1 2024.
2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.